Respiratory Synctial Virus Infections Clinical Trials
2 recruiting trials for Respiratory Synctial Virus Infections. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT06856967
Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.
This study aims to evaluate the impact of Nirsevimab, a monoclonal antibody used for RSV prophylaxis, on reducing RSV- related hospitalizations. It will be conducted at 8...
Sponsor: Meyer Children's Hospital IRCCSEnrolling: 1388 locations
RECRUITINGPhase 3NCT06775405
A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Respiratory syncytial virus (RSV) is the most common respiratory infectious pathogen recognized worldwide that poses serious health risks to infants, and an important cause of...
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.Enrolling: 18018 locations